Ventyx Biosciences (VTYX) Institutional Ownership $1.53 -0.06 (-3.77%) Closing price 04:00 PM EasternExtended Trading$1.54 +0.01 (+0.98%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Ventyx Biosciences (NASDAQ:VTYX)CurrentInstitutional OwnershipPercentage97.88%Number ofInstitutional Buyers(last 12 months)60TotalInstitutional Inflows(last 12 months)$56.29MNumber ofInstitutional Sellers(last 12 months)22TotalInstitutional Outflows(last 12 months)$21.15M Get VTYX Insider Trade Alerts Want to know when executives and insiders are buying or selling Ventyx Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VTYX Institutional Buying and Selling by Quarter Ventyx Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025Acadian Asset Management LLC537,054$614K0.0%+443.8%0.755% 5/19/2025 Jane Street Group LLC48,635$56K0.0%N/A0.068% 5/16/2025 Goldman Sachs Group Inc.593,248$682K0.0%-60.7%0.834% 5/16/2025 AQR Capital Management LLC880,222$1.01M0.0%+925.6%1.237% 5/16/2025 ADAR1 Capital Management LLC281,600$324K0.1%+126.1%0.396% 5/15/2025 Redmile Group LLC1,569,793$1.81M0.2%+1,164.1%2.206% 5/14/2025 Ieq Capital LLC194,189$223K0.0%N/A0.273% 5/14/2025 Walleye Capital LLC504,245$580K0.0%+5.5%0.709% 5/12/2025 Nuveen LLC168,420$194K0.0%N/A0.237% 5/12/2025 Invesco Ltd.117,062$135K0.0%-19.6%0.165% Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/9/2025 Charles Schwab Investment Management Inc.448,345$516K0.0%-8.3%0.630% 5/8/2025 Monaco Asset Management SAM1,134,444$1.31M0.3%+372.7%1.594% 5/8/2025 XTX Topco Ltd48,951$56K0.0%-50.8%0.069% 5/1/2025 Cutter & CO Brokerage Inc.54,000$62K0.0%N/A0.076% 5/1/2025 CWM LLC53,088$61K0.0%+1,733.8%0.075% 4/30/2025 Cerity Partners LLC49,106$56K0.0%N/A0.069% 4/16/2025 Wealth Enhancement Advisory Services LLC24,483$28K0.0%N/A0.034% 4/8/2025 Rhumbline Advisers85,928$99K0.0%-35.3%0.121% 2/17/2025 Woodline Partners LP213,240$467K0.0%N/A0.302% 2/17/2025 Velan Capital Investment Management LP35,000$77K0.1%N/A0.049% 2/17/2025 Vestal Point Capital LP2,000,000$4.38M0.3%+15.9%2.828% 2/17/2025 Squarepoint Ops LLC62,990$138K0.0%-12.3%0.089% 2/17/2025 Wexford Capital LP398,463$873K0.1%-11.3%0.564% 2/17/2025 Two Sigma Investments LP476,291$1.04M0.0%+79.8%0.674% 2/17/2025 Two Sigma Advisers LP800,800$1.75M0.0%+72.1%1.132% 2/17/2025 Shay Capital LLC124,615$273K0.0%N/A0.176% 2/17/2025 Redmile Group LLC124,178$272K0.0%-94.1%0.176% 2/17/2025 Point72 Asset Management L.P.1,782,007$3.90M0.0%N/A2.520% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC244,000$534K0.0%+22.0%0.345% 2/17/2025 Millennium Management LLC1,281,629$2.81M0.0%+369.7%1.812% 2/17/2025 Jacobs Levy Equity Management Inc.479,212$1.05M0.0%-15.7%0.678% 2/17/2025 D. E. Shaw & Co. Inc.52,231$114K0.0%-51.0%0.074% 2/17/2025 Deerfield Management Company L.P. Series C534,737$1.17M0.0%-92.0%0.756% 2/17/2025 Bank of America Corp DE4,273,442$9.36M0.0%+376.4%6.044% 2/17/2025 BNP Paribas Financial Markets126,143$276K0.0%N/A0.178% 2/14/2025 Northern Trust Corp485,664$1.06M0.0%+4.3%0.687% 2/14/2025 Boothbay Fund Management LLC314,891$690K0.0%+472.2%0.445% 2/14/2025 Susquehanna Fundamental Investments LLC198,947$436K0.0%N/A0.281% 2/14/2025 Price T Rowe Associates Inc. MD41,286$91K0.0%-24.8%0.058% 2/14/2025 MetLife Investment Management LLC26,731$59K0.0%+76.0%0.038% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos2/14/2025 Dimensional Fund Advisors LP158,288$347K0.0%N/A0.224% 2/13/2025 Walleye Capital LLC477,788$1.05M0.0%+22.5%0.676% 2/13/2025 XTX Topco Ltd99,423$218K0.0%-11.8%0.141% 2/13/2025 Mariner LLC22,105$48K0.0%-27.7%0.031% 2/13/2025 Barclays PLC91,669$200K0.0%+14.2%0.130% 2/13/2025 Renaissance Technologies LLC624,500$1.37M0.0%+99.1%0.883% 2/13/2025 ADAR1 Capital Management LLC124,530$273K0.1%+27.1%0.176% 2/13/2025 Wells Fargo & Company MN41,170$90K0.0%+23.3%0.058% 2/12/2025 Geode Capital Management LLC1,413,039$3.10M0.0%+1.5%1.998% 2/12/2025 JPMorgan Chase & Co.928,589$2.03M0.0%-7.8%1.313% 2/11/2025 AXQ Capital LP13,154$29K0.0%N/A0.019% 2/11/2025 American Century Companies Inc.67,329$147K0.0%+12.4%0.095% 2/11/2025 Virtu Financial LLC86,385$189K0.0%N/A0.122% 2/10/2025 Monaco Asset Management SAM240,000$526K0.1%N/A0.339% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.871,527$1.91M0.0%+88.6%1.233% 1/30/2025 Palumbo Wealth Management LLC23,932$52K0.0%+97.1%0.034% 1/30/2025 Rhumbline Advisers132,825$291K0.0%+44.4%0.188% 1/24/2025 Catalina Capital Group LLC11,456$25K0.0%N/A0.016% 1/17/2025 SG Americas Securities LLC25,150$55K0.0%-27.5%0.036% 12/26/2024 JPMorgan Chase & Co.1,007,519$2.20M0.0%+2.0%1.425% 11/19/2024 Barclays PLC80,295$175K0.0%+273.1%0.114% 11/16/2024 Geode Capital Management LLC1,391,702$3.03M0.0%+5.9%1.968% 11/15/2024 Barclays PLC80,295$175K0.0%+273.1%0.114% 11/15/2024 XTX Topco Ltd112,713$246K0.0%N/A0.159% 11/15/2024 Jane Street Group LLC42,272$92K0.0%-71.0%0.060% 11/15/2024 State Street Corp1,187,650$2.59M0.0%+0.8%1.680% 11/15/2024 Redmile Group LLC2,107,215$4.59M0.3%-2.6%2.980% 11/15/2024 Point72 DIFC Ltd34,589$75K0.0%-48.1%0.049% 11/15/2024 Ikarian Capital LLC192,647$420K0.1%-56.5%0.272% 11/15/2024 Jacobs Levy Equity Management Inc.568,479$1.24M0.0%+19.5%0.804% 11/15/2024 Point72 Asia Singapore Pte. Ltd.12,096$26K0.0%-52.2%0.017% 11/14/2024 Vestal Point Capital LP1,725,000$3.76M0.3%+31.2%2.440% 11/14/2024 Sio Capital Management LLC1,971,948$4.30M1.7%+153.2%2.789% 11/14/2024 Walleye Capital LLC390,102$850K0.0%-23.6%0.552% 11/14/2024 MetLife Investment Management LLC15,188$33K0.0%-54.5%0.021% 11/12/2024 Charles Schwab Investment Management Inc.485,101$1.06M0.0%+3.8%0.686% 11/9/2024 Intech Investment Management LLC19,161$42K0.0%N/A0.027% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.462,170$1.01M0.0%+10.2%0.654% 11/7/2024 LMR Partners LLP100,000$218K0.0%N/A0.142% 10/28/2024 Palumbo Wealth Management LLC12,140$26K0.0%N/A0.017% 10/25/2024 China Universal Asset Management Co. Ltd.13,592$30K0.0%+64.1%0.019% 10/3/2024 SG Americas Securities LLC34,670$76K0.0%+149.8%0.049% 9/16/2024 Point72 DIFC Ltd66,615$154K0.0%N/A0.094% 9/16/2024 Cubist Systematic Strategies LLC149,500$345K0.0%+165.8%0.212% 9/16/2024 Point72 Asia Singapore Pte. Ltd.25,303$58K0.0%N/A0.036% 8/15/2024 The Manufacturers Life Insurance Company24,349$56K0.0%+41.1%0.035% 8/15/2024 Dark Forest Capital Management LP38,126$88K0.0%N/A0.054% 8/15/2024 Deerfield Management Company L.P. Series C5,829,570$13.47M0.2%+64.6%8.269% 8/15/2024 AQR Capital Management LLC56,551$131K0.0%N/A0.080% 8/15/2024 Point72 Asia Singapore Pte. Ltd.25,303$58K0.0%N/A0.036% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos8/14/2024 Squarepoint Ops LLC76,539$177K0.0%+101.3%0.109% 8/14/2024 Cubist Systematic Strategies LLC149,500$345K0.0%+165.8%0.212% 8/14/2024 Point72 DIFC Ltd66,615$154K0.0%N/A0.094% 8/8/2024 American Century Companies Inc.25,883$60K0.0%N/A0.037% 8/6/2024Acadian Asset Management LLC263,565$608K0.0%N/A0.374% 8/1/2024 Rhumbline Advisers90,331$209K0.0%+38.0%0.128% 7/26/2024 Bank of New York Mellon Corp230,593$533K0.0%+58.4%0.327% 7/12/2024 SG Americas Securities LLC13,878$32K0.0%N/A0.020% 7/10/2024 Simplicity Wealth LLC22,361$52K0.0%-24.0%0.032% 5/29/2024 Opaleye Management Inc.1,285,000$7.07M1.5%+12.7%1.823% (Data available from 1/1/2016 forward) VTYX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VTYX shares? During the previous two years, 132 institutional investors and hedge funds held shares of Ventyx Biosciences. The most heavily invested institutionals were FMR LLC ($301.37M), Lord Abbett & CO. LLC ($60.06M), Wellington Management Group LLP ($46.64M), Loomis Sayles & Co. L P ($43.69M), Adage Capital Partners GP L.L.C. ($34.31M), Driehaus Capital Management LLC ($31.59M), and venBio Partners LLC ($26.35M).Learn more on VTYX's institutional investors. What percentage of Ventyx Biosciences stock is owned by institutional investors? 97.88% of Ventyx Biosciences stock is owned by institutional investors. Learn more on VTYX's institutional investor holdings. Which institutional investors have been buying Ventyx Biosciences stock? Of the 110 institutional investors that purchased Ventyx Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Redmile Group LLC ($3.40M), Bank of America Corp DE ($3.38M), Farallon Capital Management LLC ($3.17M), Deerfield Management Company L.P. Series C ($2.29M), Point72 Asset Management L.P. ($1.78M), Opaleye Management Inc. ($1.29M), and Sio Capital Management LLC ($1.19M). How much institutional buying is happening at Ventyx Biosciences? Institutional investors have bought a total of 31,150,918 shares in the last 24 months. This purchase volume represents approximately $212.42M in transactions. Which Ventyx Biosciences major shareholders have been selling company stock? Of the 44 institutional investors that sold Ventyx Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($6.18M), Redmile Group LLC ($2.05M), Goldman Sachs Group Inc. ($917.51K), Lord Abbett & CO. LLC ($587.71K), Capital International Investors ($373.70K), Avidity Partners Management LP ($337.60K), and Qiming U.S. Ventures Management LLC ($334.15K). How much institutional selling is happening at Ventyx Biosciences? Institutional investors have sold a total of 12,905,257 shares in the last 24 months. This volume of shares sold represents approximately $87.61M in transactions. Related Companies Entrada Therapeutics Institutional Ownership Olema Pharmaceuticals Institutional Ownership Benitec Biopharma Institutional Ownership Arcturus Therapeutics Institutional Ownership Heron Therapeutics Institutional Ownership Septerna Institutional Ownership Fulcrum Therapeutics Institutional Ownership Atyr PHARMA Institutional Ownership Atai Life Sciences Institutional Ownership Aurora Cannabis Institutional Ownership This page (NASDAQ:VTYX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.